Logo image of DAP.DE

DANAHER CORP (DAP.DE) Stock Price, Quote, News and Overview

FRA:DAP - Deutsche Boerse Ag - US2358511028 - Common Stock - Currency: EUR

171.84  -4.18 (-2.37%)

DAP.DE Quote, Performance and Key Statistics

DANAHER CORP

FRA:DAP (5/6/2025, 7:00:00 PM)

171.84

-4.18 (-2.37%)

Sector
GICS SectorHealth Care
GICS IndustryLife Sciences Tools & Services
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryLife Sciences Tools & Services
Statistics
52 Week High260
52 Week Low149.72
Market Cap122.98B
Shares715.67M
Float636.59M
Yearly Dividend0.93
Dividend Yield0.65%
PE26.12
Fwd PE22.39
Earnings (Next)07-21 2025-07-21/amc
IPO12-10 1969-12-10


DAP.DE short term performance overview.The bars show the price performance of DAP.DE in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 -5 -10 -15 -20 -25

DAP.DE long term performance overview.The bars show the price performance of DAP.DE in the last 1, 2 and 3 years. 1 year 2 years 3 years -5 -10 -15 -20 -25

The current stock price of DAP.DE is 171.84 EUR. In the past month the price decreased by -5.46%. In the past year, price decreased by -26.69%.

DANAHER CORP / DAP Daily stock chart

DAP.DE Competitors/Peers

The largest stocks on the EU markets in the "Life Sciences Tools & Services" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
1TMO.MI THERMO FISHER SCIENTIFIC INC 19.17 139.97B
TN8.DE THERMO FISHER SCIENTIFIC INC 18.93 138.24B
56S1.DE SARTORIUS STEDIM BIOTECH 55.66 20.59B
DIM.PA SARTORIUS STEDIM BIOTECH 54.32 20.09B
SRT3.DE SARTORIUS AG-VORZUG 53.7 17.17B
SRT.DE SARTORIUS AG 43.7 13.97B
ILU.DE ILLUMINA INC 31.29 10.70B
ESF0.DE EUROFINS SCIENTIFIC 31.77 10.42B
ERF.PA EUROFINS SCIENTIFIC 31.22 10.24B
QIA.DE QIAGEN N.V. 19.16 8.07B
1SXP.DE SCHOTT PHARMA AG& CO KGAA 27.98 3.75B
EVT.DE EVOTEC SE N/A 2.49B

About DAP.DE

Company Profile

DAP logo image Danaher Corp. engages in the design, manufacture, and marketing of professional, medical, industrial, and commercial products and services. The company is headquartered in Washington, Washington Dc and currently employs 61,000 full-time employees. The firm operates through three segments: Biotechnology, Life Sciences and Diagnostics. The Biotechnology segment includes the bioprocessing and discovery and medical businesses and offers a broad range of equipment, consumables and services that are primarily used by customers to advance and accelerate the research, development, manufacture and delivery of biological medicines. The Life Sciences segment offers a broad range of instruments, consumables, services and software that are primarily used by customers to study the basic building blocks of life, including deoxyribonucleic acid (DNA) and ribonucleic acid (RNA), nucleic acid, proteins, metabolites and cells. The Diagnostics segment offers clinical instruments, consumables, software and services that hospitals, physicians’ offices, reference laboratories and other critical care settings use to diagnose disease and make treatment decisions.

Company Info

DANAHER CORP

2200 Pennsylvania Ave NW Ste 800W

WASHINGTON WASHINGTON DC US

Employees: 61000

DAP Company Website

DAP Investor Relations

Phone: 12028280850

DANAHER CORP / DAP.DE FAQ

What is the stock price of DANAHER CORP today?

The current stock price of DAP.DE is 171.84 EUR. The price decreased by -2.37% in the last trading session.


What is the ticker symbol for DANAHER CORP stock?

The exchange symbol of DANAHER CORP is DAP and it is listed on the Deutsche Boerse Ag exchange.


On which exchange is DAP.DE stock listed?

DAP.DE stock is listed on the Deutsche Boerse Ag exchange.


What is the price forecast or stock price prediction for DANAHER CORP stock?

32 analysts have analysed DAP.DE and the average price target is 222.45 EUR. This implies a price increase of 29.45% is expected in the next year compared to the current price of 171.84. Check the DANAHER CORP stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is DANAHER CORP worth?

DANAHER CORP (DAP.DE) has a market capitalization of 122.98B EUR. This makes DAP.DE a Large Cap stock.


How many employees does DANAHER CORP have?

DANAHER CORP (DAP.DE) currently has 61000 employees.


What are the support and resistance levels for DANAHER CORP (DAP.DE) stock?

DANAHER CORP (DAP.DE) has a resistance level at 173.48. Check the full technical report for a detailed analysis of DAP.DE support and resistance levels.


Is DANAHER CORP (DAP.DE) expected to grow?

The Revenue of DANAHER CORP (DAP.DE) is expected to grow by 2.91% in the next year. Check the estimates tab for more information on the DAP.DE EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy DANAHER CORP (DAP.DE) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does DANAHER CORP (DAP.DE) stock pay dividends?

DANAHER CORP (DAP.DE) has a dividend yield of 0.65%. The yearly dividend amount is currently 0.93. Check the full fundamental report for a detailed analysis of DAP.DE dividend history, reliability and sustainability.


When does DANAHER CORP (DAP.DE) report earnings?

DANAHER CORP (DAP.DE) will report earnings on 2025-07-21, after the market close.


What is the Price/Earnings (PE) ratio of DANAHER CORP (DAP.DE)?

The PE ratio for DANAHER CORP (DAP.DE) is 26.12. This is based on the reported non-GAAP earnings per share of 6.58 and the current share price of 171.84 EUR. Check the full fundamental report for a full analysis of the valuation metrics for DAP.DE.


DAP.DE Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating

DAP.DE Fundamental Analysis

ChartMill assigns a fundamental rating of 6 / 10 to DAP.DE. DAP.DE scores excellent points on both the profitability and health parts. This is a solid base for a good stock.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

DAP.DE Financial Highlights

Over the last trailing twelve months DAP.DE reported a non-GAAP Earnings per Share(EPS) of 6.58. The EPS decreased by -7.8% compared to the year before.


Industry RankSector Rank
PM (TTM) 15.81%
ROA 4.76%
ROE 7.4%
Debt/Equity 0.31
Chartmill High Growth Momentum
EPS Q2Q%-2.08%
Sales Q2Q%-0.95%
EPS 1Y (TTM)-7.8%
Revenue 1Y (TTM)0.35%

DAP.DE Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 85% to DAP.DE. The Buy consensus is the average rating of analysts ratings from 32 analysts.

For the next year, analysts expect an EPS growth of 3.51% and a revenue growth 2.91% for DAP.DE


Ownership
Inst Owners81.31%
Ins Owners10.97%
Short Float %N/A
Short RatioN/A
Analysts
Analysts85
Price Target222.45 (29.45%)
EPS Next Y3.51%
Revenue Next Year2.91%